Ryo Nishikawa

Saitama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 180 publications

Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Journal: Oncogene

Published: July 02, 2026

Post-marketing surveillance of tirabrutinib for Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma in Japan.

Post-marketing surveillance of tirabrutinib for Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma in Japan.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: March 15, 2026

Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.

Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.

Journal: Journal of neuro-oncology

Published: February 09, 2026

Comparing artificial intelligence and physician performance in predicting IDH mutation status in glioma.

Comparing artificial intelligence and physician performance in predicting IDH mutation status in glioma.

Journal: NPJ digital medicine

Published: January 01, 2026

Safety and Efficacy of Tumor-Treating Fields (TTFields) Therapy for Pediatric High-Grade Glioma: Results of a Prespecified Interim Analysis of the First Three Cases.

Safety and Efficacy of Tumor-Treating Fields (TTFields) Therapy for Pediatric High-Grade Glioma: Results of a Prespecified Interim Analysis of the First Three Cases.

Journal: Children (Basel, Switzerland)

Published: December 03, 2025

Framework for Statistical Parametric Mapping of the Interactions between Glioblastoma Location, Treatment, Prognostic Variables, and Survival Using a Phase III Trial.

Framework for Statistical Parametric Mapping of the Interactions between Glioblastoma Location, Treatment, Prognostic Variables, and Survival Using a Phase III Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 18, 2025

A Nationwide Central Diagnosis for Pediatric CNS Tumors in Japan: The JCCG Brain Tumor and Pathology Committees.

A Nationwide Central Diagnosis for Pediatric CNS Tumors in Japan: The JCCG Brain Tumor and Pathology Committees.

Journal: Cancer science

Published: November 11, 2025

Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.

Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.

Journal: Journal of neuro-oncology

Published: November 01, 2025

Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.

Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.

Journal: Journal of neuro-oncology

Published: November 01, 2025

Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphoma.

Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphoma.

Journal: Future oncology (London, England)

Published: October 31, 2025

Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods.

Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods.

Journal: Brain pathology (Zurich, Switzerland)

Published: October 23, 2025

Retraction of Activation of Rac1 by Src-dependent phosphorylation of Dock180Y1811 mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans.

Retraction of Activation of Rac1 by Src-dependent phosphorylation of Dock180Y1811 mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans.

Journal: The Journal of clinical investigation

Published: September 16, 2025

Showing 1-12 of 180

Last Updated: 09/26/2026